A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

Walter Fiedler; Joerg Chromik; Stefanie Amberg; Maxim Kebenko; Felicitas Thol; Vera Schlipfenbacher; Anne Christine Wilke; Franziska Modemann; Melanie Janning; Hubert Serve; Arnold Ganser; Carsten Bokemeyer; Susann Theile; Ute Deppermann; Anne L Kranich; Michael Heuser

doi:10.1111/bjh.16804

A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

Walter Fiedler, Joerg Chromik, Stefanie Amberg, Maxim Kebenko, Felicitas Thol, Vera Schlipfenbacher, Anne Christine Wilke, Franziska Modemann, Melanie Janning, Hubert Serve, Arnold Ganser, Carsten Bokemeyer, Susann Theile, Ute Deppermann, Anne L Kranich, Michael Heuser

Klinik für Hämatologie und Onkologie

Originalsprache	Englisch
Zeitschrift	British Journal of Haematology
Jahrgang	190
Ausgabenummer	3
Seiten (von - bis)	e169-e173
ISSN	0007-1048
DOIs	https://doi.org/10.1111/bjh.16804
Publikationsstatus	Veröffentlicht - 08.2020

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Zugriff auf Dokument

10.1111/bjh.16804

Zitieren

Fiedler, W., Chromik, J., Amberg, S., Kebenko, M., Thol, F., Schlipfenbacher, V., Christine Wilke, A., Modemann, F., Janning, M., Serve, H., Ganser, A., Bokemeyer, C., Theile, S., Deppermann, U., Kranich, A. L., & Heuser, M. (2020). A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia. British Journal of Haematology, 190(3), e169-e173. https://doi.org/10.1111/bjh.16804

@article{853387d63c594afb81cdc6326de9179b,

title = "A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia",

author = "Walter Fiedler and Joerg Chromik and Stefanie Amberg and Maxim Kebenko and Felicitas Thol and Vera Schlipfenbacher and {Christine Wilke}, Anne and Franziska Modemann and Melanie Janning and Hubert Serve and Arnold Ganser and Carsten Bokemeyer and Susann Theile and Ute Deppermann and Kranich, {Anne L} and Michael Heuser",

year = "2020",

month = aug,

doi = "10.1111/bjh.16804",

language = "English",

volume = "190",

pages = "e169--e173",

journal = "British Journal of Haematology",

issn = "0007-1048",

number = "3",

}

Fiedler, W, Chromik, J, Amberg, S, Kebenko, M, Thol, F, Schlipfenbacher, V, Christine Wilke, A, Modemann, F, Janning, M, Serve, H, Ganser, A, Bokemeyer, C, Theile, S, Deppermann, U, Kranich, AL & Heuser, M 2020, 'A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia', British Journal of Haematology, Jg. 190, Nr. 3, S. e169-e173. https://doi.org/10.1111/bjh.16804

TY - JOUR

T1 - A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia

AU - Fiedler, Walter

AU - Chromik, Joerg

AU - Amberg, Stefanie

AU - Kebenko, Maxim

AU - Thol, Felicitas

AU - Schlipfenbacher, Vera

AU - Christine Wilke, Anne

AU - Modemann, Franziska

AU - Janning, Melanie

AU - Serve, Hubert

AU - Ganser, Arnold

AU - Bokemeyer, Carsten

AU - Theile, Susann

AU - Deppermann, Ute

AU - Kranich, Anne L

AU - Heuser, Michael

PY - 2020/8

Y1 - 2020/8

U2 - 10.1111/bjh.16804

DO - 10.1111/bjh.16804

M3 - Journal articles

C2 - 32515072

SN - 0007-1048

VL - 190

SP - e169-e173

JO - British Journal of Haematology

JF - British Journal of Haematology

IS - 3

ER -